Please ensure Javascript is enabled for purposes of website accessibility

Better Buy: CVS Health Corporation vs. Wal-Mart Stores

By Brian Feroldi - Mar 20, 2017 at 9:08AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Which of these retail giants is the better choice for new money today?

Retailing is a tough business. Building a lasting competitive advantage in the industry is extremely challenging, which is one reason so many retailers have gone belly-up. 

Despite the industry dynamics, CVS Health (CVS 2.33%) and Wal-Mart Stores (WMT 0.08%) are two retailers that have thrived over the long term. But given the ever-changing retail landscape, which of these two companies is more worthy of an investment today?

money with arrows pointing out in different directions

Image Source: Getty Images.

The case for Wal-Mart

It's a tough time to be in the big-box retailing business. More customers are choosing to shop online, which is making it difficult for stores to attract foot traffic. Meanwhile, dollar stores are also trying to nibble away at Wal-Mart's market share.

Wal-Mart is not taking the renewed sense of competition lightly. In fact, Wal-Mart has gotten quite serious about making its e-commerce presence known. Last year, the company shelled out $3.3 billion to buy Jet.com, a fast-growing e-commerce concept. More recently, it spent about $70 million to acquire ShoeBuy.com, a direct competitor to Amazon.com's Zappos. 

So far, it looks as if the company's aggressive actions are paying off. Last quarter, Wal-Mart's e-commerce sales grew by 29%. That's a strong number, though given Wal-Mart's size it will probably take quite some time before e-commerce sales start to move the needle. 

As for Wal-Mart's retail stores themselves, the company appears to be holding its own against the dollar stores. Same-store sales in the U.S. grew by 1.8% last quarter, driven primarily by foot-traffic gains. That's a decent result that shows that Wal-Mart's brand and perceived value have staying power.

Despite these positive signs, Wall Street isn't expecting the company's bottom line to grow by much. Over the next five years, analysts are projecting EPS growth of roughly 4%. That low number could be caused by concerns that margin will take a hit as wages for workers rise. It's also worth pointing out that Jet.com was an unprofitable business when Wal-Mart acquired it, so the division is also likely to be a headwind to profits.

While the profit growth isn't all that exciting, Wal-Mart does offer investors a 2.9% dividend yield. Those aren't terrible figures for a company that's trading for only 16 times trailing earnings.

The case for CVS Health

Most consumers know that CVS Health runs a retail pharmacy empire, but this industry giant is actually two big businesses in one. 

On the retail side, CVS operates more than 9,700 locations in the U.S., Puerto Rico, and Brazil. This business took a significant leap forward last year when management paid $1.9 billion to acquire Target's pharmacies and clinics. This one move grew the company's footprint by more than 20% and provided the company with direct access to millions of potential customers. That's helped revenue grow at a decent clip.

Beyond retail, CVS also operates the second largest pharmacy benefits management business in the United States. This business unit caters to providers of healthcare benefits -- think unions and governments. CVS earns a small fee from these in exchange for negotiating hefty discounts on pharmaceuticals directly from drug manufacturers. This is a win-win business model that accounts for the bulk of CVS's revenue. 

Looking ahead, CVS Health has a number of initiatives in place that promise to drive growth. The list includes growing its MinuteClinic footprint, persuading Target customers to make the switch, and driving growth in its specialty pharmaceutical business. When adding cost-savings initiatives and share buybacks to the mix, Wall Street believes that CVS Health's bottom line will grow by more than 10% annually over the next five years. Plus, the company pays a respectable 2.5% dividend yield and is trading at only 16 times trailing earnings.

The better buy

While Wal-Mart offers investors a slightly higher dividend yield at the moment, I think CVS Health is the smarter bet. The company offers investors much better growth prospects for a comparable valuation. It also doesn't help Wal-Mart's case to see that Warren Buffett has been dumping his big position in the company recently.

If you're after a battle-tested retailer that offers income and growth, I think that CVS Health is a terrific choice. 

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$94.52 (2.33%) $2.15
Wal-Mart Stores, Inc. Stock Quote
Wal-Mart Stores, Inc.
WMT
$123.72 (0.08%) $0.10

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.